$AYTU

Aytu Biopharma, Inc

Nasdaq · Healthcare · Pharmaceutical Preparations · Denver, CO

AYTU chart

What traders are saying about $AYTU

Latest posts

Aytu Biopharma, Inc news

Aytu Biopharma, Inc key financials

USD2026202520242023
Revenue$57.6M$66.4M$65.2M$107.4M
Net income-$14.3M-$13.6M-$15.8M-$17.1M
Diluted EPS–––$-5.11
Total assets (year end)–$122.0M$116.2M$131.2M
Cash and equivalents (year end)–$30.0M$20.4M$19.5M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Aytu Biopharma, Inc

Ticker
AYTU (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Denver, CO
Incorporated in
DE
Fiscal year end
June 30
SEC CIK
1385818
Former names
AYTU BIOSCIENCE, INC, Rosewind CORP

Frequently asked questions

What exchange is Aytu Biopharma, Inc listed on?

Aytu Biopharma, Inc trades on the Nasdaq under the ticker symbol AYTU.

What industry is Aytu Biopharma, Inc in?

Aytu Biopharma, Inc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is Aytu Biopharma, Inc headquartered?

Aytu Biopharma, Inc's business address on file with the SEC is in Denver, CO.

When does Aytu Biopharma, Inc's fiscal year end?

Aytu Biopharma, Inc's fiscal year ends on June 30.

How much revenue did Aytu Biopharma, Inc report?

Aytu Biopharma, Inc reported $57.6M in revenue for calendar year 2026, according to its SEC filings.